Figures

Figure 1. Lymphoma risk in patients with AD treated with TCIs or TCS based on results from a meta-analysis performed by Legendre et al. (2015) (76). TCIs: topical calcineurin inhibitors; TCS: topical corticosteroids CI: confidence interval